Paperpal Prime Logo

Leukemia : Impact Factor & More

eISSN: 1476-5551pISSN: 0887-6924

Aims and Scope of Leukemia

Leukemia is a peer-reviewed medical journal published by the Nature Publishing Group. It was established in 1987 by Nicole Muller-Bérat Killman and Sven-Aage Killman, and is currently edited by Professors Andreas Hochhaus and Robert Peter Gale. The journal covers research on all aspects of leukemia and has a 2019 impact factor of 8.665. Less

Key Metrics

CiteScore
17.6
Eigenfactor
0.01 - 0.05
H-Index
211
Impact Factor
10 - 15
Scite Index
0.91 5-Year SI
SJR
Q1Oncology
SNIP
2.69
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Leukemia

Leukemia Journal Specifications

Overview
Publisher SPRINGERNATURE
Language English
Frequency Monthly
General Details
LanguageEnglish
FrequencyMonthly
Publication Start Year1987
Publisher URLVisit website
Website URLVisit website
View less

Planning to publish in Leukemia ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Leukemia

FATP2-mediated lipid metabolism enhances chimeric antigen receptor T-cell therapy resistance in B-cell acute lymphoblastic leukemia.
  • 30 Jun 2026
  • Leukemia
Unpacking the epigenetic landscape of acute lymphoblastic leukemia: resolving cellular heterogeneity and nutritional complexities.
  • 30 Jun 2026
  • Leukemia
Lineage-restricted dependency on an oncofetal SNHG29-IGF2BP1 RNA axis in acute megakaryoblastic leukemia.
  • 30 Jun 2026
  • Leukemia
Spatial remodeling of bone marrow architecture defines tissue-state signatures of disease activity and therapeutic response in myelodysplastic neoplasms.
  • 30 Jun 2026
  • Leukemia
Selective targeting of RSK signaling with PMD-026 suppresses FLT3-activated acute myeloid leukemia while sparing normal hematopoiesis.
  • 30 Jun 2026
  • Leukemia
Selective sensitivity of Ph-like B-cell acute lymphoblastic leukemia to BRG1 inhibition identifies a therapeutic vulnerability.
  • 30 Jun 2026
  • Leukemia
FATP2-mediated lipid metabolism enhances chimeric antigen receptor T-cell therapy resistance in B-cell acute lymphoblastic leukemia.
  • 30 Jun 2026
  • Leukemia
Unpacking the epigenetic landscape of acute lymphoblastic leukemia: resolving cellular heterogeneity and nutritional complexities.
  • 30 Jun 2026
  • Leukemia
Lineage-restricted dependency on an oncofetal SNHG29-IGF2BP1 RNA axis in acute megakaryoblastic leukemia.
  • 30 Jun 2026
  • Leukemia
Spatial remodeling of bone marrow architecture defines tissue-state signatures of disease activity and therapeutic response in myelodysplastic neoplasms.
  • 30 Jun 2026
  • Leukemia
Selective targeting of RSK signaling with PMD-026 suppresses FLT3-activated acute myeloid leukemia while sparing normal hematopoiesis.
  • 30 Jun 2026
  • Leukemia
Selective sensitivity of Ph-like B-cell acute lymphoblastic leukemia to BRG1 inhibition identifies a therapeutic vulnerability.
  • 30 Jun 2026
  • Leukemia

FAQs on Leukemia